- Home
- DEC vs QDEL Comparison
DEC vs QDEL Comparison
Compare DEC & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DEC | QDEL |
|---|---|---|
| Founded | 2001 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DEC | QDEL |
|---|---|---|
| Price | $15.61 | $10.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 4 |
| Target Price | $22.29 | ★ $28.25 |
| AVG Volume (30 Days) | 610.6K | ★ 2.9M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 7.09% | N/A |
| EPS Growth | ★ 311.06 | 45.35 |
| EPS | N/A | ★ N/A |
| Revenue | $1,829,142,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $26.53 | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 141.54 | N/A |
| 52 Week Low | $12.33 | $10.21 |
| 52 Week High | $18.90 | $35.58 |
Technical Indicators
Market Signals| Indicator | DEC | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 46.44 | 35.11 |
| Support Level | $14.47 | $10.86 |
| Resistance Level | $15.88 | $17.78 |
| Average True Range (ATR) | 0.41 | 0.93 |
| MACD | -0.06 | 0.08 |
| Stochastic Oscillator | 31.25 | 20.58 |
Price Performance
Historical ComparisonAbout DEC Diversified Energy Company plc
Diversified Energy Co engaged in the production, transportation, and marketing of natural gas, NGLs, and oil, managing a diversified portfolio of mature, long-life assets located across the United States. The company derives revenues from the sale of oil, natural gas and natural gas liquids.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.